Ensign Peak Advisors, Inc
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$244,767
+$45,629 QoQ
Shares Held
6,578
+4.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#172
of 252 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. CLDX ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in CLDX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244,767 | 6,578 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $199,138 | 6,278 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $170,510 | 6,278 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $410,763 | 15,878 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $489,987 | 24,078 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $437,015 | 24,078 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $592,025 | 23,428 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $796,317 | 23,428 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $867,070 | 23,428 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,488,665 | 178,429 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,123,372 | 179,611 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,535,390 | 92,129 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,125,936 | 92,129 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,314,801 | 92,129 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,106,189 | 92,129 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $301,058 | 10,710 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $288,741 | 10,710 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $364,782 | 10,710 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $413,834 | 10,710 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||